Advertisement|Remove ads.

UnitedHealth Group Inc. (UNH) shares gained more than 7% in pre-market trading on Tuesday after a strong quarter, but more importantly, its outlook shift and improved margin signals caught investors' attention. The insurer raised its full-year 2026 earnings outlook and announced a $2 billion share buyback.
UnitedHealth raised its FY2026 adjusted earnings guidance to more than $18.25 per share. It had previously guided for earnings of $17.75 per share. This is above Wall Street’s estimates of $17.87 per share, according to Fiscal.ai.
The company also announced plans to repurchase at least $2 billion worth of its shares by the end of the second quarter (Q2) under its existing buyback program.
UnitedHealth Group’s first quarter (Q1) revenues came in 1.9% higher at $111.7 billion, beating Street estimates. The insurer’s Q1 adjusted net earnings of $7.23 per share were well above the consensus estimates of $6.61 per share.
UnitedHealth Group’s medical cost ratio (MCR) was 83.9% for Q1, down 90 basis points from last year. The MCR improved by 20 basis points due to a previously disclosed reserve related to loss-making Optum Health contracts, the company said. The MCR represents the share of revenue spent on medical claims; a higher ratio indicates that costs are rising faster than revenue.
The company said Q1 operating margin increased to 6.6% from 6.% a year earlier, primarily driven by pricing adjustments across all business segments to offset elevated cost trends seen in the insurance space.
UnitedHealth also mentioned that its acquisition of Alegeus Technologies to expand its consumer-focused healthcare solutions is expected to close in late 2026.
Retail sentiment on Stocktwits for UNH flipped to ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes. UNH was also among the top trending tickers at the time of writing.
One user expects the stock to climb to $500 by the end of the year.
Another user expects a multi-day run on the back of the Q1 results.
Earlier this month, Morgan Stanley named UnitedHealth as ‘Top Pick’, adding that it “is not necessarily a call on the quarter, but a call on what should be a string of clean quarters that should drive incremental enthusiasm.”
Meanwhile, Jefferies raised its price target to $373 from $340 and maintained a ‘Buy’ rating, according to The Fly.
UNH stock has shed around 2% so far this year.
For updates and corrections, email newsroom[at]stocktwits[dot]com.